Cortical lesions, central vein sign, and paramagnetic rim lesions in
  multiple sclerosis: emerging machine learning techniques and future avenues
  The current multiple sclerosis (MS) diagnostic criteria lack specificity, and
this may lead to misdiagnosis, which remains an issue in present-day clinical
practice. In addition, conventional biomarkers only moderately correlate with
MS disease progression. Recently, advanced MS lesional imaging biomarkers such
as cortical lesions (CL), the central vein sign (CVS), and paramagnetic rim
lesions (PRL), visible in specialized magnetic resonance imaging (MRI)
sequences, have shown higher specificity in differential diagnosis. Moreover,
studies have shown that CL and PRL are potential prognostic biomarkers, the
former correlating with cognitive impairments and the latter with early
disability progression. As machine learning-based methods have achieved
extraordinary performance in the assessment of conventional imaging biomarkers,
such as white matter lesion segmentation, several automated or semi-automated
methods have been proposed for CL, CVS, and PRL as well. In the present review,
we first introduce these advanced MS imaging biomarkers and their imaging
methods. Subsequently, we describe the corresponding machine learning-based
methods that were used to tackle these clinical questions, putting them into
context with respect to the challenges they are still facing, including
non-standardized MRI protocols, limited datasets, and moderate inter-rater
variability. We conclude by presenting the current limitations that prevent
their broader deployment and suggesting future research directions.
